Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ -4,893
▼ 108% vs 2024
Profit
Caution€ -5,479
▼ 88% vs 2024
Debts
Low€ 2,797
▲ 95% vs 2024
PROGRESS PHARMA from Vosselaar, company number BE0536258560, closed financial year 2025 with a result of € -5,479 after tax. For that financial year PROGRESS PHARMA recorded a gross margin of € -4,893 and equity of € 47,137. Compared with financial year 2024, the result moved from € -2,921 to € -5,479. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 5, 2026.
What happened at PROGRESS PHARMA?
What happened at PROGRESS PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 5,479. Source: NBB ↗
- New establishment in Vosselaar. KBO
- Start of the company according to the CBE. KBO
In short
From € 2,202 loss in 2021 to € 5,479 loss in 2025.
A new publication or filing at PROGRESS PHARMA? We notify you, reason included.
Follow PROGRESS PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind PROGRESS PHARMA are Luc Lammens, SALVEGEN HEALTHCARE BV, R&S CONSULTING BV, SIMBIOSIS.LIFE BV and CONCORDE CONSULTING BV. It owns 100% of Etherna immunotherapies itself.
Directors
According to the 2025 annual accounts
SALVEGEN HEALTHCARE BV
Managing director · represented by Emilius VAN DONGEN
Director · represented by Marina COOLS
Director · represented by Dirk VAN BROEKHOVEN
Establishments
Establishment units
Physical locations of this company
Roekendreef 14
2350 Vosselaar
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0536.258.560
- VAT number
- BE 0536.258.560
- Registered office
- Roekendreef 14, 2350 Vosselaar
- Names & denominations
- PROGRESS PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 June 2013
- Peppol
- Active · Active since 4 Jun 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige zakelijke dienstverlening, neg